Symmetry Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Out of Business
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Out of Business

Symmetry Therapeutics General Information

Description

Provider of a mitochondrial carrier drug platform intended to treat common and rare metabolic diseases. The company's platform target metabolite carrier proteins, enabling patients to get meaningful therapeutic options.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1210 East Columbia Avenue
  • Philadelphia, PA 19125
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Symmetry Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Aug-2018 Completed Out of Business
1. Product Crowdfunding 10-Oct-2015 000.00 Completed Startup
To view Symmetry Therapeutics’s complete valuation and funding history, request access »

Symmetry Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial